Trials that use: MMRM (mixed model for repeated measures)
New to this method? Read the tutorial →
3,067 results
- ASDIndependent statistical analysis of Development of a Resiliency Training Program for Parents of Children With Autism Spectrum Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ASPECCTIndependent statistical analysis of ASPECCT, the randomized phase 3 comparison of panitumumab and cetuximab in patients with KRAS wild-type metastatic colorectal cancer, including non-inferiority analysis, hazard ratios, response, patient-reported outcomes, and safety.
- ASPENIndependent statistical analysis of the phase 3 ASPEN trial of brensocatib 10 mg and 25 mg versus placebo in non-cystic fibrosis bronchiectasis, covering negative binomial rate ratios for pulmonary exacerbations, Cox, logistic…
- ASPIREIndependent statistical analysis of Coaching Veterans to Healthy Weights and Wellness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00967668).
- ASPIREIndependent statistical analysis of Family-Focused, Stress-Reduction Program to Improve the Health Care of Urban Children With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers: Complete Statistical AnalysisIndependent statistical analysis of Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Aspirin for Treatment of Multiple Sclerosis-Related Fatigue: Complete Statistical AnalysisIndependent statistical analysis of Aspirin for Treatment of Multiple Sclerosis-Related Fatigue: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00467584).
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer: Complete Statistical AnalysisIndependent statistical analysis of Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.: Complete Statistical AnalysisIndependent statistical analysis of Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Assessing Neuroinflammation in GWI Using MRS: Complete Statistical AnalysisIndependent statistical analysis of Assessing Neuroinflammation in GWI Using MRS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04638998).
- Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI: Complete Statistical AnalysisIndependent statistical analysis of Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03367312).
- Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on Brimonidine 0.2%/Timolol 0.5% Fixed Combination Therapy (COMBIGAN®) in Latin America:…
- Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Impacts of a UESAD on Laryngeal Symptoms and Salivary Pepsin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Assessment of Alcon’s Ocular Image Quantification System: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Alcon's Ocular Image Quantification System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01282138).
- Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Assessment of Cough Reflex in Lung Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Cough Reflex in Lung Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00584077).
- Assessment of Dystussia in Traumatic Brain Injury: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Dystussia in Traumatic Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02240329).
- Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Assessment of Pharmacokinetics of Single Dose Odanacatib (MK-0822) in Participants With Moderate Hepatic Insufficiency (MK-0822-070): Complete Statistical AnalysisIndependent statistical analysis of Assessment of Pharmacokinetics of Single Dose Odanacatib (MK-0822) in Participants With Moderate Hepatic Insufficiency (MK-0822-070): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Assessment of the Effect of PAP on Energy and Vitality in Mild OSA Patients: The Merge Study: Complete Statistical AnalysisIndependent statistical analysis of Assessment of the Effect of PAP on Energy and Vitality in Mild OSA Patients: The Merge Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Assessment of Two New Electronic Cigarettes in Cigarette Smokers: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Two New Electronic Cigarettes in Cigarette Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03435562).
- ASSUREIndependent statistical analysis of Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- AsthmaCareIndependent statistical analysis of Randomized Prospective Trial of a Mobile Health Application for Asthma Self-Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- At-Home Telehealth Yoga for Treating Chronic Pain in People With Alzheimer’s Disease and Their Caregiver’s: Complete Statistical AnalysisIndependent statistical analysis of At-Home Telehealth Yoga for Treating Chronic Pain in People With Alzheimer's Disease and Their Caregiver's: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Atacicept in Subjects With Optic Neuritis: Complete Statistical AnalysisIndependent statistical analysis of Atacicept in Subjects With Optic Neuritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00624468).
- ATLASIndependent statistical analysis of Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Atomoxetine and Huntington’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Atomoxetine and Huntington's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00368849).
- Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD): Complete Statistical AnalysisIndependent statistical analysis of Atomoxetine to Treat Korean Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility: Complete Statistical AnalysisIndependent statistical analysis of Atomoxetine/Attention Deficit/ Hyperactive Disorder (ADHD)/Substance Use Disorder (SUD)in a Residential Treatment Facility: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Attachment Based Family Therapy for Suicidal Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Attachment Based Family Therapy for Suicidal Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01537419).
- Attention Bias Modification Training for Young People: Complete Statistical AnalysisIndependent statistical analysis of Attention Bias Modification Training for Young People: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02270671).
- Audiobooks for Hearing Loss App as Auditory Training: Complete Statistical AnalysisIndependent statistical analysis of Audiobooks for Hearing Loss App as Auditory Training: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04231396).
- Audiovisual Aid Pilot Study: Complete Statistical AnalysisIndependent statistical analysis of Audiovisual Aid Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02506673).
- Augmenting Effects of L-DOPS With Carbidopa and Entacapone: Complete Statistical AnalysisIndependent statistical analysis of Augmenting Effects of L-DOPS With Carbidopa and Entacapone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00547911).
- Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Augmenting Growth Hormone to Ameliorate Nonalcoholic Fatty Liver Disease in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- AUR0613Independent statistical analysis of Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- AutonomyIndependent statistical analysis of A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04619420).
- AVALLIndependent statistical analysis of Assessment of an School-based Intervention in Eating Habits and Physical Activity in Schoolchildren: the AVall Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Avenir Müller Hip Stem Post Market Surveillance Study: Complete Statistical AnalysisIndependent statistical analysis of Avenir Müller Hip Stem Post Market Surveillance Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04079127).
- AVR_HEORIndependent statistical analysis of EaseVRx-8w+ for the Treatment of Chronic Lower Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05263037).
- AWARD-2Independent statistical analysis of A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01075282).
- AWARD-CHN3Independent statistical analysis of A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- AWARD-JPNIndependent statistical analysis of A Study of Two Doses of Dulaglutide (LY2189265) in Japanese Patients With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- AWARD-PEDSIndependent statistical analysis of A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania: Complete Statistical AnalysisIndependent statistical analysis of Awareness Enhancement and Monitoring Device for Treatment of Trichotillomania: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01654523).
- AZI001Independent statistical analysis of Azithromycin in Bronchiolitis Obliterans Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01009619).
- AZMATICS: AZithroMycin/Asthma Trial In Community Settings: Complete Statistical AnalysisIndependent statistical analysis of AZMATICS: AZithroMycin/Asthma Trial In Community Settings: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00266851).